Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
Clinical trial NCT02353780 · TERMINATED
Trial details
- NCT number
- NCT02353780
- Sponsor
- Dr. Larry W. Moreland
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.